Cargando…
Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis
Visceral leishmaniasis caused by Leishmania donovani is the most severe systemic form of the disease. There are still no vaccines available for humans and there are limitations associated with the current therapeutic regimens for leishmaniasis. Recently, we reported functional importance of Arabino-...
Autores principales: | Anand, Sneha, Madhubala, Rentala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451804/ https://www.ncbi.nlm.nih.gov/pubmed/26035062 http://dx.doi.org/10.1038/srep10706 |
Ejemplares similares
-
Glyoxalase I Gene Deletion Mutants of Leishmania donovani Exhibit Reduced Methylglyoxal Detoxification
por: Chauhan, Swati C., et al.
Publicado: (2009) -
Hemophagocytosis in Experimental Visceral Leishmaniasis by Leishmania donovani
por: Morimoto, Ayako, et al.
Publicado: (2016) -
The mitochondrial SIR2 related protein 2 (SIR2RP2) impacts Leishmania donovani growth and infectivity
por: Mittal, Nimisha, et al.
Publicado: (2017) -
Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani
por: Duthie, Malcolm S, et al.
Publicado: (2019) -
Genetic Validation of Leishmania donovani Lysyl-tRNA Synthetase Shows that It Is Indispensable for Parasite Growth and Infectivity
por: Chadha, Sanya, et al.
Publicado: (2017)